SCHEMBL13829275

SCHEMBL13829275

COc1ccc([C@H]2Oc3cc(C)cc(OC)c3C[C@@H]2O)cc1OC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.62
▸ MAPK1 P28482 3/20 0.62
▸ MAPT P10636 3/20 0.62
▸ THRB P10828 1/20 0.62
▸ ABCB1 P08183 4/20 0.58
▸ GABRA1 P14867 1/20 0.46
▸ GABRB2 P47870 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ PTGS1 P23219 3/20 0.44
▸ MAPK14 Q16539 1/20 0.44
▸ BACE1 P56817 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ PKM P14618 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ APEX1 P27695 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ APP P05067 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26481045 0.88 CYP3A4 (0.50) CYP3A4MAPK1MAPTTHRBABCB1
Catechin Tetramethylether SCHEMBL12632524 0.88 CYP3A4 (0.81) CYP3A4MAPK1MAPTTHRBABCB1
Catechin Tetramethylether SCHEMBL1430853 0.88 CYP3A4 (0.81) CYP3A4MAPK1MAPTTHRBABCB1
Catechin Tetramethylether SCHEMBL30991591 0.88 CYP3A4 (0.81) CYP3A4MAPK1MAPTTHRBABCB1
Catechin Tetramethylether SCHEMBL30178011 0.88 CYP3A4 (0.81) CYP3A4MAPK1MAPTTHRBABCB1
Catechin Tetramethylether SCHEMBL28731348 0.88 CYP3A4 (0.81) CYP3A4MAPK1MAPTTHRBABCB1
SCHEMBL12573080 0.84 CYP3A4 (0.61) CYP3A4MAPK1MAPTTHRBABCB1
SCHEMBL26481134 0.82 BACE1 (0.59) CYP3A4MAPK1MAPTABCB1ALDH1A1
SCHEMBL31028352 0.81 BACE1 (0.69) CYP3A4MAPK1MAPTTHRBALDH1A1
SCHEMBL5924559 0.81 BACE1 (0.69) CYP3A4MAPK1MAPTTHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296717-B2 Synthesis of C-3 coupled biflavonoids and C-3 coupled biflavonoid analogues UNIVERSITY OF THE FREE STATE (ZA) 2016-03-29 — — US disclosed
US-20120289715-A1 Synthesis of C-3 Coupled Biflavonoids and C-3 Coupled Biflavonoid Analogues UNIVERSITY OF THE FREE STATE (ZA) 2012-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289715-A1 Synthesis of C-3 Coupled Biflavonoids and C-3 Coupled Biflavonoid Analogues CBR3, C9, PROC CYP3A4 115/4885MAPK1 1501/4885MAPT 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback